Long-Term Outcomes in Adults with Ischemic Heart Disease Using Cardiac MRI Imaging Markers

What this Trial Is About

Ischemic heart disease IHD is a major cause of illness and death worldwide, making accurate risk assessment crucial for better patient care and outcomes. This research investigates how detailed heart imaging using cardiovascular magnetic resonance CMR can help predict long-term risks in patients with ischemic heart conditions. The study uses existing clinical and imaging data from multiple centers to explore the value of various imaging markers in assessing heart damage and function. The study focuses on analyzing CMR images taken during routine clinical care. Key imaging features examined include late gadolinium enhancement LGE to detect heart tissue scarring, infarct size, microvascular obstruction MVO, strain measurements of the hearts left chambers, and T1 and T2 mapping values. Data from these images, along with patient demographics, risk factors, treatments, and follow-up information, will be studied to understand their relationship with major cardiovascular events and death. Participants medical records will be reviewed retrospectively to collect long-term outcomes, including major adverse cardiovascular and cerebrovascular events MACCE and cardiovascular death, over up to 10 years after their CMR exam. This observational study does not involve new treatments but analyzes existing data to improve risk prediction. The findings aim to help personalize patient care by clarifying how CMR imaging can guide long-term management of ischemic heart disease.

CMR Prognostic Markers in Ischemic Heart Disease